nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—DRD2—Gilles de la Tourette syndrome	0.491	0.564	CbGaD
Lurasidone—HTR2A—Gilles de la Tourette syndrome	0.38	0.436	CbGaD
Lurasidone—HTR7—autonomic nervous system—Gilles de la Tourette syndrome	0.00715	0.228	CbGeAlD
Lurasidone—DRD2—Dopamine receptors—DRD3—Gilles de la Tourette syndrome	0.00476	0.0527	CbGpPWpGaD
Lurasidone—DRD2—Dopamine receptors—DRD4—Gilles de la Tourette syndrome	0.00462	0.0512	CbGpPWpGaD
Lurasidone—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00446	0.142	CbGeAlD
Lurasidone—Ziprasidone—DRD4—Gilles de la Tourette syndrome	0.00257	0.342	CrCbGaD
Lurasidone—HTR7—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.0023	0.0255	CbGpPWpGaD
Lurasidone—Ziprasidone—DRD3—Gilles de la Tourette syndrome	0.00221	0.295	CrCbGaD
Lurasidone—HTR7—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0019	0.021	CbGpPWpGaD
Lurasidone—HTR1A—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.0017	0.0189	CbGpPWpGaD
Lurasidone—HTR7—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00162	0.0179	CbGpPWpGaD
Lurasidone—HTR7—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00157	0.0174	CbGpPWpGaD
Lurasidone—Ziprasidone—DRD2—Gilles de la Tourette syndrome	0.00153	0.204	CrCbGaD
Lurasidone—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.00151	0.0167	CbGpPWpGaD
Lurasidone—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.00147	0.0162	CbGpPWpGaD
Lurasidone—HTR7—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00146	0.0162	CbGpPWpGaD
Lurasidone—HTR1A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0014	0.0156	CbGpPWpGaD
Lurasidone—ADRA2C—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00136	0.0151	CbGpPWpGaD
Lurasidone—HTR7—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00136	0.0151	CbGpPWpGaD
Lurasidone—HTR7—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00132	0.0146	CbGpPWpGaD
Lurasidone—DRD2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00123	0.0137	CbGpPWpGaD
Lurasidone—HTR7—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00123	0.0136	CbGpPWpGaD
Lurasidone—HTR2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00121	0.0134	CbGpPWpGaD
Lurasidone—HTR1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0012	0.0133	CbGpPWpGaD
Lurasidone—Ziprasidone—HTR2A—Gilles de la Tourette syndrome	0.00118	0.158	CrCbGaD
Lurasidone—HTR1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00116	0.0129	CbGpPWpGaD
Lurasidone—ADRA2C—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00116	0.0128	CbGpPWpGaD
Lurasidone—HTR1A—midbrain—Gilles de la Tourette syndrome	0.00115	0.0366	CbGeAlD
Lurasidone—ADRA2C—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00113	0.0125	CbGpPWpGaD
Lurasidone—ADRA2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0011	0.0122	CbGpPWpGaD
Lurasidone—HTR7—midbrain—Gilles de la Tourette syndrome	0.0011	0.035	CbGeAlD
Lurasidone—HTR1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00108	0.012	CbGpPWpGaD
Lurasidone—DRD2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00105	0.0117	CbGpPWpGaD
Lurasidone—ADRA2C—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00105	0.0116	CbGpPWpGaD
Lurasidone—DRD2—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.00105	0.0116	CbGpPWpGaD
Lurasidone—DRD2—midbrain—Gilles de la Tourette syndrome	0.00104	0.0331	CbGeAlD
Lurasidone—HTR2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00104	0.0115	CbGpPWpGaD
Lurasidone—HTR7—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00102	0.0113	CbGpPWpGaD
Lurasidone—DRD2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00102	0.0113	CbGpPWpGaD
Lurasidone—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.00101	0.0322	CbGeAlD
Lurasidone—HTR1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00101	0.0112	CbGpPWpGaD
Lurasidone—HTR2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.001	0.0111	CbGpPWpGaD
Lurasidone—HTR1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000978	0.0108	CbGpPWpGaD
Lurasidone—ADRA2C—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000975	0.0108	CbGpPWpGaD
Lurasidone—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000947	0.0301	CbGeAlD
Lurasidone—ADRA2C—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000946	0.0105	CbGpPWpGaD
Lurasidone—ADRA2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000942	0.0104	CbGpPWpGaD
Lurasidone—HTR2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.000936	0.0104	CbGpPWpGaD
Lurasidone—ADRA2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000914	0.0101	CbGpPWpGaD
Lurasidone—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000912	0.029	CbGeAlD
Lurasidone—HTR1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000911	0.0101	CbGpPWpGaD
Lurasidone—HTR7—nervous system—Gilles de la Tourette syndrome	0.000905	0.0288	CbGeAlD
Lurasidone—DRD2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000884	0.00979	CbGpPWpGaD
Lurasidone—ADRA2C—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000881	0.00976	CbGpPWpGaD
Lurasidone—HTR7—central nervous system—Gilles de la Tourette syndrome	0.000871	0.0277	CbGeAlD
Lurasidone—HTR2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00087	0.00964	CbGpPWpGaD
Lurasidone—HTR7—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000861	0.00953	CbGpPWpGaD
Lurasidone—DRD2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000858	0.00951	CbGpPWpGaD
Lurasidone—DRD2—nervous system—Gilles de la Tourette syndrome	0.000855	0.0272	CbGeAlD
Lurasidone—ADRA2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.000852	0.00943	CbGpPWpGaD
Lurasidone—HTR2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000845	0.00936	CbGpPWpGaD
Lurasidone—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.000832	0.0265	CbGeAlD
Lurasidone—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000824	0.0262	CbGeAlD
Lurasidone—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000807	0.0257	CbGeAlD
Lurasidone—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.000801	0.0255	CbGeAlD
Lurasidone—ADRA2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000792	0.00877	CbGpPWpGaD
Lurasidone—HTR2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000787	0.00872	CbGpPWpGaD
Lurasidone—ADRA2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000768	0.00851	CbGpPWpGaD
Lurasidone—HTR1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000759	0.00841	CbGpPWpGaD
Lurasidone—ADRA2C—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000734	0.00813	CbGpPWpGaD
Lurasidone—HTR1A—brain—Gilles de la Tourette syndrome	0.000724	0.023	CbGeAlD
Lurasidone—HTR7—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.000718	0.00795	CbGpPWpGaD
Lurasidone—ADRA2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000716	0.00793	CbGpPWpGaD
Lurasidone—HTR7—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000697	0.00772	CbGpPWpGaD
Lurasidone—HTR7—brain—Gilles de la Tourette syndrome	0.000692	0.022	CbGeAlD
Lurasidone—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000686	0.0218	CbGeAlD
Lurasidone—DRD2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000666	0.00738	CbGpPWpGaD
Lurasidone—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000664	0.0211	CbGeAlD
Lurasidone—DRD2—brain—Gilles de la Tourette syndrome	0.000654	0.0208	CbGeAlD
Lurasidone—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000639	0.0203	CbGeAlD
Lurasidone—HTR1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000638	0.00707	CbGpPWpGaD
Lurasidone—ADRA2C—brain—Gilles de la Tourette syndrome	0.000636	0.0202	CbGeAlD
Lurasidone—ADRA2C—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000617	0.00684	CbGpPWpGaD
Lurasidone—ADRA2A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000596	0.00661	CbGpPWpGaD
Lurasidone—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000564	0.0179	CbGeAlD
Lurasidone—DRD2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00056	0.0062	CbGpPWpGaD
Lurasidone—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000543	0.0173	CbGeAlD
Lurasidone—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000522	0.0166	CbGeAlD
Lurasidone—ADRA2A—brain—Gilles de la Tourette syndrome	0.000507	0.0161	CbGeAlD
Lurasidone—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000503	0.016	CbGeAlD
Lurasidone—ADRA2A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000501	0.00555	CbGpPWpGaD
Lurasidone—HTR2A—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00046	0.00509	CbGpPWpGaD
Lurasidone—HTR7—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.000455	0.00504	CbGpPWpGaD
Lurasidone—HTR2A—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000446	0.00494	CbGpPWpGaD
Lurasidone—HTR2A—brain—Gilles de la Tourette syndrome	0.000431	0.0137	CbGeAlD
Lurasidone—HTR7—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000381	0.00422	CbGpPWpGaD
Lurasidone—HTR7—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00037	0.0041	CbGpPWpGaD
Lurasidone—HTR7—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000345	0.00382	CbGpPWpGaD
Lurasidone—HTR7—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000312	0.00346	CbGpPWpGaD
Lurasidone—HTR7—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000303	0.00336	CbGpPWpGaD
Lurasidone—HTR7—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000282	0.00313	CbGpPWpGaD
Lurasidone—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000267	0.00296	CbGpPWpGaD
Lurasidone—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00026	0.00287	CbGpPWpGaD
Lurasidone—HTR1A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000249	0.00276	CbGpPWpGaD
Lurasidone—DRD2—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000248	0.00275	CbGpPWpGaD
Lurasidone—HTR1A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000242	0.00268	CbGpPWpGaD
Lurasidone—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000242	0.00268	CbGpPWpGaD
Lurasidone—ADRA2C—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000241	0.00267	CbGpPWpGaD
Lurasidone—DRD2—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000241	0.00267	CbGpPWpGaD
Lurasidone—ADRA2C—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000234	0.00259	CbGpPWpGaD
Lurasidone—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000231	0.00256	CbGpPWpGaD
Lurasidone—HTR1A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000225	0.0025	CbGpPWpGaD
Lurasidone—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000224	0.00249	CbGpPWpGaD
Lurasidone—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000224	0.00248	CbGpPWpGaD
Lurasidone—HTR1A—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000219	0.00243	CbGpPWpGaD
Lurasidone—DRD2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000219	0.00242	CbGpPWpGaD
Lurasidone—ADRA2C—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000218	0.00241	CbGpPWpGaD
Lurasidone—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000217	0.00241	CbGpPWpGaD
Lurasidone—DRD2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000212	0.00235	CbGpPWpGaD
Lurasidone—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000209	0.00232	CbGpPWpGaD
Lurasidone—HTR7—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000204	0.00225	CbGpPWpGaD
Lurasidone—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000203	0.00225	CbGpPWpGaD
Lurasidone—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000202	0.00224	CbGpPWpGaD
Lurasidone—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0002	0.00221	CbGpPWpGaD
Lurasidone—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000198	0.00219	CbGpPWpGaD
Lurasidone—HTR7—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000198	0.00219	CbGpPWpGaD
Lurasidone—HTR7—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000198	0.00219	CbGpPWpGaD
Lurasidone—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000197	0.00218	CbGpPWpGaD
Lurasidone—ADRA2A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000196	0.00217	CbGpPWpGaD
Lurasidone—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000194	0.00215	CbGpPWpGaD
Lurasidone—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000192	0.00213	CbGpPWpGaD
Lurasidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000192	0.00212	CbGpPWpGaD
Lurasidone—ADRA2A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00019	0.00211	CbGpPWpGaD
Lurasidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000186	0.00206	CbGpPWpGaD
Lurasidone—HTR7—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000184	0.00204	CbGpPWpGaD
Lurasidone—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000182	0.00201	CbGpPWpGaD
Lurasidone—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000181	0.002	CbGpPWpGaD
Lurasidone—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000179	0.00198	CbGpPWpGaD
Lurasidone—ADRA2A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000177	0.00196	CbGpPWpGaD
Lurasidone—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000176	0.00195	CbGpPWpGaD
Lurasidone—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000174	0.00193	CbGpPWpGaD
Lurasidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000173	0.00192	CbGpPWpGaD
Lurasidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000171	0.0019	CbGpPWpGaD
Lurasidone—HTR7—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000169	0.00188	CbGpPWpGaD
Lurasidone—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000169	0.00187	CbGpPWpGaD
Lurasidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000166	0.00184	CbGpPWpGaD
Lurasidone—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000164	0.00182	CbGpPWpGaD
Lurasidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000156	0.00172	CbGpPWpGaD
Lurasidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000155	0.00171	CbGpPWpGaD
Lurasidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000151	0.00167	CbGpPWpGaD
Lurasidone—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000151	0.00167	CbGpPWpGaD
Lurasidone—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000146	0.00162	CbGpPWpGaD
Lurasidone—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000146	0.00162	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000146	0.00162	CbGpPWpGaD
Lurasidone—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000142	0.00157	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000142	0.00157	CbGpPWpGaD
Lurasidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000141	0.00156	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—HDC—Gilles de la Tourette syndrome	0.00014	0.00155	CbGpPWpGaD
Lurasidone—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000136	0.00151	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000132	0.00147	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000132	0.00146	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00013	0.00144	CbGpPWpGaD
Lurasidone—HTR7—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000129	0.00143	CbGpPWpGaD
Lurasidone—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000129	0.00142	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000129	0.00142	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000127	0.0014	CbGpPWpGaD
Lurasidone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000125	0.00139	CbGpPWpGaD
Lurasidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000121	0.00134	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000119	0.00131	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000118	0.00131	CbGpPWpGaD
Lurasidone—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000115	0.00127	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000115	0.00127	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000115	0.00127	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	0.000114	0.00126	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000112	0.00124	CbGpPWpGaD
Lurasidone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00011	0.00122	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000107	0.00119	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000104	0.00116	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000104	0.00115	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000101	0.00112	CbGpPWpGaD
Lurasidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	9.86e-05	0.00109	CbGpPWpGaD
Lurasidone—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	9.56e-05	0.00106	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	9.45e-05	0.00105	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	9.25e-05	0.00102	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.53e-05	0.000944	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	8.39e-05	0.000929	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.28e-05	0.000917	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.25e-05	0.000914	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.01e-05	0.000887	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.74e-05	0.000857	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.71e-05	0.000854	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.52e-05	0.000832	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.51e-05	0.000832	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.49e-05	0.00083	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.49e-05	0.000829	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.46e-05	0.000826	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.37e-05	0.000816	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	7.29e-05	0.000807	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.27e-05	0.000805	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.27e-05	0.000805	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.15e-05	0.000792	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	7e-05	0.000775	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.8e-05	0.000753	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.77e-05	0.00075	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.7e-05	0.000742	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.69e-05	0.000741	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.66e-05	0.000738	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	6.62e-05	0.000733	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.6e-05	0.000731	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.5e-05	0.00072	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.49e-05	0.000719	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	6.17e-05	0.000684	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.08e-05	0.000674	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.06e-05	0.000671	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.05e-05	0.00067	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	5.99e-05	0.000664	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.91e-05	0.000654	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.58e-05	0.000618	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.5e-05	0.000609	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.4e-05	0.000598	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.23e-05	0.000579	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.9e-05	0.000543	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	4.84e-05	0.000536	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.75e-05	0.000526	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.74e-05	0.000525	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.57e-05	0.000507	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.44e-05	0.000492	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.43e-05	0.00049	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.31e-05	0.000477	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.3e-05	0.000476	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.24e-05	0.00047	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.14e-05	0.000458	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.02e-05	0.000445	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4e-05	0.000443	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.95e-05	0.000438	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.91e-05	0.000433	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.9e-05	0.000432	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.85e-05	0.000427	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.84e-05	0.000425	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.59e-05	0.000398	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.57e-05	0.000396	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.49e-05	0.000386	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.25e-05	0.00036	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.9e-05	0.000321	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.8e-05	0.00031	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.54e-05	0.000282	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.28e-05	0.000252	CbGpPWpGaD
